EQS-News: SYNBIOTIC SE / Key word(s): Alliance IRIS Capital invests in SYNBIOTIC's growth strategy 17.04.2025 / 14:14 CET/CEST The issuer is solely responsible for the content of this announcement. IRIS Capital invests in SYNBIOTIC's growth strategy The European medical cannabis and industrial hemp group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) and the venture capital company IRIS Capital Investment have entered into a strategic partnership. The French investment company will actively...
EQS-News: SYNBIOTIC SE / Key word(s): Product Launch SYNBIOTIC presents medical cannabis as a pastille for the German market for the first time 01.04.2025 / 15:13 CET/CEST The issuer is solely responsible for the content of this announcement. SYNBIOTIC presents medical cannabis as a pastille for the German market for the first time SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5), the European group of companies specialising in medical cannabis and industrial hemp, is launching medical cannabis...
EQS-News: SYNBIOTIC SE / Key word(s): Statement/Product Launch Quo vadis legalisation: SYNBIOTIC and GOC NEXUS at the International Cannabis Business Conference (ICBC) in Berlin 13.03.2025 / 11:14 CET/CEST The issuer is solely responsible for the content of this announcement. Quo vadis legalisation: SYNBIOTIC and GOC NEXUS at the International Cannabis Business Conference (ICBC) in Berlin The European industrial hemp and cannabis company group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) will...
EQS-News: SYNBIOTIC SE / Key word(s): Mergers & Acquisitions/Strategic Company Decision SYNBIOTIC with four new investments in 2024: Further acquisitions in sight for 2025 10.01.2025 / 11:44 CET/CEST The issuer is solely responsible for the content of this announcement. SYNBIOTIC with four new investments in 2024: Further acquisitions in sight for 2025 The European industrial hemp and cannabis group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) is planning further strategically important...
EQS-News: SYNBIOTIC SE / Key word(s): Investment Trend-setting decontamination: SYNBIOTIC and GOC NEXUS set the gold standard for cannabis 18.12.2024 / 13:06 CET/CEST The issuer is solely responsible for the content of this announcement. The European industrial hemp and cannabis group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) announced a strategic partnership with GOC NEXUS OPERATIONS GmbH on 13 December 2024. This collaboration marks a significant step in the further development and...
EQS-News: SYNBIOTIC SE / Key word(s): Mergers & Acquisitions SYNBIOTIC integrates greensby: Universal platform for the entire hemp and cannabis industry 25.11.2024 / 11:39 CET/CEST The issuer is solely responsible for the content of this announcement. The European hemp and cannabis group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) announces the integration of greensby with the acquisition of 50.2 % of the shares. This strategic move creates a unique platform that bundles all of the Group's...
EQS-News: SYNBIOTIC SE / Key word(s): Miscellaneous In full bloom: WEECO Pharma boosts SYNBIOTIC's sales 14.11.2024 / 13:30 CET/CEST The issuer is solely responsible for the content of this announcement. The acquisition of WEECO Pharma by the European hemp and cannabis group SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) is proving to be a valuable deal in the truest sense of the word. WEECO Pharma is well above the previously planned revenue target for 2024, at EUR 6.75 million as of the end of...
EQS-News: SYNBIOTIC SE / Key word(s): AGM/EGM Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval 27.09.2024 / 11:19 CET/CEST The issuer is solely responsible for the content of this announcement. The Annual General Meeting of SYNBIOTIC SE (ISIN DE000A3E5A59 | WKN A3E5A5) has confirmed the strategic growth course of the European industrial hemp and cannabis company group with an overwhelming majority. At the virtual Annual...
